{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:09:19Z","timestamp":1787504959741,"version":"build-2736575974"},"reference-count":39,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,5,29]]},"published-print":{"date-parts":[[2025,8]]},"DOI":"10.2967\/jnumed.125.269653","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:25:14Z","timestamp":1751559914000},"page":"1223-1231","source":"Crossref","is-referenced-by-count":3,"title":["A Prospective Provincial Registry of\n                    <sup>18<\/sup>\n                    F-PSMA PET\/CT for Recurrent Prostate Cancer: Results for 4,135 Men"],"prefix":"10.2967","volume":"66","author":[{"given":"Andres","family":"Kohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur","family":"Metser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"MacCrostie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Shayegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Pautler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon","family":"Hagerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke T.","family":"Lavall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2025080106551287000_66.8.1223.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025080106551287000_66.8.1223.2","unstructured":"SEER Cancer Stat Facts 2024: prostate cancer. National Cancer Institute website. https:\/\/seer.cancer.gov\/. Accessed June 18, 2025."},{"key":"2025080106551287000_66.8.1223.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.09.028"},{"key":"2025080106551287000_66.8.1223.4","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1200\/JCO.2022.40.16_suppl.5090","article-title":"Recurrence, metastasis, and survival after radical prostatectomy in the era of advanced treatments [abstract]","volume":"40","author":"Stensland","year":"2022","journal-title":"J Clin Oncol."},{"key":"2025080106551287000_66.8.1223.5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1148\/radiol.211824","article-title":"Effect of 18F-DCFPyL PET\/CT on the management of patients with recurrent prostate cancer: results of a prospective multicenter registry trial","volume":"303","author":"Metser","year":"2022","journal-title":"Radiology."},{"key":"2025080106551287000_66.8.1223.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02411-1"},{"key":"2025080106551287000_66.8.1223.7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","article-title":"Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer\u2014a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2025080106551287000_66.8.1223.8","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00259-022-05693-0","article-title":"Diagnostic accuracy of [18F]PSMA-1007 PET\/CT in biochemical recurrence of prostate cancer","volume":"49","author":"Mingels","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025080106551287000_66.8.1223.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00644"},{"key":"2025080106551287000_66.8.1223.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4853"},{"key":"2025080106551287000_66.8.1223.11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncol."},{"key":"2025080106551287000_66.8.1223.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00985"},{"key":"2025080106551287000_66.8.1223.13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-019-6117-z","article-title":"Radioablation +\/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)","volume":"19","author":"Marvaso","year":"2019","journal-title":"BMC Cancer."},{"key":"2025080106551287000_66.8.1223.14","doi-asserted-by":"crossref","first-page":"S2643","DOI":"10.1016\/S0167-8140(24)03363-2","article-title":"3381: Primary endpoint analysis of TRAP, first prospective phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303)","volume":"194","author":"Patel","year":"2024","journal-title":"Radiother Oncol."},{"key":"2025080106551287000_66.8.1223.15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2025080106551287000_66.8.1223.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263006"},{"key":"2025080106551287000_66.8.1223.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265874"},{"key":"2025080106551287000_66.8.1223.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.029"},{"key":"2025080106551287000_66.8.1223.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2025080106551287000_66.8.1223.20","doi-asserted-by":"crossref","first-page":"722430","DOI":"10.3389\/fonc.2021.722430","article-title":"Establishing a provincial registry for recurrent prostate cancer: providing access to PSMA PET\/CT in Ontario, Canada","volume":"11","author":"Young","year":"2021","journal-title":"Front Oncol."},{"key":"2025080106551287000_66.8.1223.21","unstructured":"Postal Code Conversion File Plus (PCCF+) version 7D, reference guide. Statistics Canada website. https:\/\/mdl.library.utoronto.ca\/sites\/default\/public\/mdldata\/open\/canada\/national\/statcan\/postalcodes\/pccfplus\/2016\/pccf_plus_7D\/Userguide-EN-19022021.pdf. Published November 2020. Accessed June 10, 2025."},{"key":"2025080106551287000_66.8.1223.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2007.07.010"},{"key":"2025080106551287000_66.8.1223.23","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(82)90058-3"},{"key":"2025080106551287000_66.8.1223.24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/tomography9040120","article-title":"Detection of biochemically recurrent prostate cancer with [18F]DCFPyL PET\/CT: an updated systematic review and meta-analysis with a focus on correlations with serum prostate-specific antigen parameters","volume":"9","author":"Sadaghiani","year":"2023","journal-title":"Tomography."},{"key":"2025080106551287000_66.8.1223.25","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s00259-021-05189-3","article-title":"Performance of [68Ga]Ga-PSMA-11 PET\/CT in patients with recurrent prostate cancer after prostatectomy\u2014a multi-centre evaluation of 2533 patients","volume":"48","author":"Afshar-Oromieh","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025080106551287000_66.8.1223.26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clgc.2022.12.007","article-title":"PSMA-11 PET\/CT for detection of recurrent prostate cancer in patients with negative choline PET\/CT","volume":"21","author":"Pinot","year":"2023","journal-title":"Clin Genitourin Cancer."},{"key":"2025080106551287000_66.8.1223.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.01.049"},{"key":"2025080106551287000_66.8.1223.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.261886"},{"key":"2025080106551287000_66.8.1223.29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00259-019-04505-2","article-title":"Prediction nomogram for 68Ga-PSMA-11 PET\/CT in different clinical settings of PSA failure after radical treatment for prostate cancer","volume":"47","author":"Ceci","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025080106551287000_66.8.1223.30","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1007\/s00259-020-04696-z","article-title":"Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET\/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng\/ml external validation on a single institution database","volume":"47","author":"Bianchi","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025080106551287000_66.8.1223.31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euo.2021.12.002","article-title":"Multicenter external validation of a nomogram for predicting positive prostate-specific membrane antigen\/positron emission tomography scan in patients with prostate cancer recurrence","volume":"6","author":"Bianchi","year":"2023","journal-title":"Eur Urol Oncol."},{"key":"2025080106551287000_66.8.1223.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265916"},{"key":"2025080106551287000_66.8.1223.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05831-8"},{"key":"2025080106551287000_66.8.1223.34","doi-asserted-by":"publisher","DOI":"10.1016\/1078-1439(95)00002-Y"},{"key":"2025080106551287000_66.8.1223.35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euo.2018.09.010","article-title":"A systematic review on the role of imaging in early recurrent prostate cancer","volume":"2","author":"De Visschere","year":"2019","journal-title":"Eur Urol Oncol."},{"key":"2025080106551287000_66.8.1223.36","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/cancers14061361","article-title":"The continuum of metastatic prostate cancer: interpreting PSMA PET findings in recurrent prostate cancer","volume":"14","author":"Kase","year":"2022","journal-title":"Cancers (Basel)."},{"key":"2025080106551287000_66.8.1223.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.235028"},{"key":"2025080106551287000_66.8.1223.38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40644-024-00752-1","article-title":"Prognostic significance of a negative PSMA PET\/CT in biochemical recurrence of prostate cancer","volume":"24","author":"Harsini","year":"2024","journal-title":"Cancer Imaging."},{"key":"2025080106551287000_66.8.1223.39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(24)00326-7","article-title":"Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study","volume":"25","author":"Karpinski","year":"2024","journal-title":"Lancet Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.269653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T13:56:10Z","timestamp":1754056570000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.269653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,1]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.2967\/jnumed.125.269653"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.269653","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}